Interactive program
Tuesday 19 March 2024
-
Standard presentation 400 Hall
Afternoon (CET)
UPDATE ON SEPSIS BIOMARKERS
Moderator(s):
Djillali Annane (Garches, France)
Lieuwe Bos (Amsterdam, Netherlands)
Lieuwe Bos (Amsterdam, Netherlands)
-
-
Bacterial or viral infection: consult the immune response
Evangelos Giamarellos–Bourboulis (Athens, Greece)
Wednesday 20 March 2024
-
Standard presentation Copper Hall
Morning (CET)
SEPSIS MANAGEMENT
Moderator(s):
Philippe Montravers (Paris, France)
Mervyn Singer (London, United Kingdom)
Mervyn Singer (London, United Kingdom)
-
-
Early risk assessment
Evangelos Giamarellos–Bourboulis (Athens, Greece)
-
Standard presentation 400 Hall
Afternoon (CET)
MIND THE GUT
Moderator(s):
Tina Palmieri (Sacramento, United States)
Julia Wendon (London, United Kingdom)
Julia Wendon (London, United Kingdom)
-
-
Probiotics: yes or no?
Evangelos Giamarellos–Bourboulis (Athens, Greece)
-
Round table The Arc Room
Afternoon (CET)
-
-
Treatable traits versus sub phenotypes
Evangelos Giamarellos–Bourboulis (Athens, Greece)
Patricia Rocco (Rio De Janeiro, Brazil)
Christopher Seymour (Pittsburgh, United States)
Manu Shankar–Hari (Edinburgh, United Kingdom)
Thursday 21 March 2024
-
Standard presentation Copper Hall
Afternoon (CET)
SEVERE PNEUMONIA
Moderator(s):
Sheila N Myatra (Mumbai, India)
Jean-Christophe Richard (Angers, France)
Jean-Christophe Richard (Angers, France)
-
-
Should we always add a macrolide?
Evangelos Giamarellos–Bourboulis (Athens, Greece)
-
Standard presentation 100 Hall
Afternoon (CET)
PERSONALIZING SEPSIS
Moderator(s):
Liesbet De Bus (Ghent, Belgium)
Mervyn Singer (London, United Kingdom)
Mervyn Singer (London, United Kingdom)
-
-
Precision immunotherapy
Evangelos Giamarellos–Bourboulis (Athens, Greece)
Friday 22 March 2024
-
Standard presentation 100 Hall
Morning (CET)
-
-
Is long-COVID associated with abnormal host responses
Evangelos Giamarellos–Bourboulis (Athens, Greece)